Jump to the top of the page

William Blair News

Keep up to date on our recent transactions, announcements, and events.

A hand holding a smartphone in front of a laptop

News and Events

  • Investment Banking

    Abry Partners and CAPZA Have Agreed to Make a Strategic Minority Investment in European Dynamics

    William Blair acted as the exclusive financial advisor to Abry Partners in connection with its pending significant minority investment in European Dynamics, alongside CAPZA.

    Read more
  • Investment Banking

    William Blair Adds Secondaries Lead in Europe

    William Blair announced today the continued growth of the firm’s Private Capital Advisory team in Europe with the addition of Tim-Oliver Seidel.

    Read more
  • Equity Research

    William Blair Initiates Coverage of Two Companies Developing Retinal Disease Therapies

    William Blair initiated research coverage of Kalaris Therapeutics, Inc. (KLRS $7.08) and Ocular Therapeutix, Inc. (OCUL $6.36), both biotechnology companies developing therapies for the treatment of retinal vascular diseases.

    Read more
  • Equity Research

    Savers Value Village, Inc.: Initiation of Research Coverage

    William Blair initiated research coverage of Savers Village Value, Inc. (SVV $7.02), the largest for-profit thrift operator in the U.S. and Canada.

    Read more
  • Equity Research

    Waste Connections, Inc.: Initiation of Research Coverage

    William Blair initiated research coverage of Waste Connections, Inc. (WCN $196.51), a vertically integrated solid waste, recycling, and E&P waste provider.

    Read more
  • Equity Research

    StoneX Group Inc.: Initiation of Research Coverage

    William Blair initiated research coverage of StoneX Group Inc., a global financial services network that connects clients to global markets through digital platforms, end-to-end clearing and execution services, and risk management solutions.

    Read more
  • Equity Research

    Immunic, Inc.: Initiation of Research Coverage

    William Blair initiated research coverage of Immunic, Inc. (IMUX $1.13), a clinical-stage biotech developing novel therapies for chronic inflammatory and autoimmune disorders.

    Read more
News search

Awards and Recognition

  • Private Wealth Management

    Record-Breaking 30 William Blair Wealth Advisors Named Best-in-State by Forbes

    Congratulations to the firm’s largest group to make Forbes’ annual state listing, released on April 8.

    Read more
  • Equity Research

    Top Wall Street Analysts

    TipRanks acknowledged five William Blair equity research analysts among the top 10%, reflecting their ability to outperform their peers with expertise and stock selection.

    Read more
  • Corporate

    William Blair Receives 2025 Top Workplaces USA Award

    William Blair earned the 2025 Top Workplaces USA during an awards ceremony held on March 19.

    Read more
  • William Blair logo etched on a glass wall
    Private Wealth Management

    15 William Blair Wealth Advisors Recognized by Barron’s

    Barron’s named 15 William Blair wealth advisors as top-in-state, released on March 7.

    Read more
  • Private Wealth Management

    Financial Planning Names William Blair Wealth Advisors to Its Top 40 Under 40 List

    William Blair’s Matt Clark and David Dreifuss were named to Financial Planning’s Top 40 Advisors Under 40 list, released February 18.

    Read more
  • Institutional Sales and Trading

    Bloomberg Intelligence Survey of Leading Equity Traders

    After being ranked for the first time in Bloomberg Intelligence’s 2024 U.S. institutional trading study for being among the 25 most widely used brokers, William Blair improved its ranking among our competitors in the 2025 list to the top 20.

    Read more
Search awards and recognition

In The Media

  • Private Wealth Management

    15 William Blair Wealth Advisors Recognized by Barron’s

    Barron’s named 15 William Blair wealth advisors as top-in-state, released on March 7.

    Read more
  • Equity Research

    Richard de Chazal Quoted in U.S. News & World Report

    William Blair macro analyst Richard de Chazal was quoted in a U.S. News & World Report story focused on February’s employment numbers and the actions of the Trump administration related to government employees and spending.

    Read more
  • Investment Management

    Yvette Babb, Dan Wood Published in Advisor Perspectives

    William Blair Investment Management portfolio managers Yvette Babb and Dan Wood were published on the topic of frontier markets debt in asset management publication Advisor Perspectives.

    Read more
  • Equity Research

    Sharon Zackfia Discusses New Starbucks CFO with MarketWatch

    William Blair research analyst Sharon Zackfia was quoted in MarketWatch on the hiring of a new CFO at Starbucks and the likely impact this will have on the future of the coffee chain.

    Read more
  • Equity Research

    Dylan Carden Featured in Sportico

    William Blair research analyst Dylan Carden was featured in sports business publication Sportico, where he discussed the investing outlook for On Holdings, backed by tennis legend Roger Federer.

    Read more
Search media mentions

Contact Us

Please contact Padraic Swanton with any media-related inquiries or to request a complete media kit.

+1 312 364 5290
pswanton@williamblair.com

For inquiries related to Equity Research, please contact Chris Thonis.

+1 312 364 8565
cthonis@williamblair.com

Delivered to Your Inbox

Stay up-to-date with the latest William Blair news and insights

Subscribe to News Alerts

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures